Global Influenza Drugs and Vaccines Market 2012-2022: Focus on Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir) & Vaccines (Trivalent, Quadrivalent)

Dublin, June 13, 2017 -- Research and Markets has announced the addition of the "Global Influenza Drugs and Vaccines Market - By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region, By Country" report to their offering.

Global market is projected to display a steady growth rate represented by a CAGR of 10.24% during 2017 - 2022, chiefly driven by increasing spending over various immunization programmes.

Rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.

The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.

Scope of the Report

Global Influenza Market (Actual Period: 2012-2016E, Forecast Period: 2017-2022)

- By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
- By Vaccine Type: Trivalent, Quadrivalent
- By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir

Other Report Highlights

- Market Dynamics - Trends, Drivers, Challenges
- Pipeline Analysis
- Company Analysis - Falvogen, Gilead Science and Bio Cryst

Key Topics Covered:

1. Influenza Market: An Introduction

2. Global Influenza Market Overview

3. Global Influenza Market, Product Analysis

4. Global Influenza Vaccines & Drugs - Pipeline Analysis

5. Global Influenza Market, By Region

6. North America Influenza Market Overview

7. United States Influenza Market Overview

8. Europe Influenza Market Overview

9. United Kingdom Influenza Market Overview

10. France Influenza Market Overview

11. APAC Influenza Market Overview

12. India Influenza Market Overview

13. China Influenza Market Overview

14. ROW Influenza Market Overview

15. Market Dynamics

16. Company Profiles

• Alvogen
• Astrazeneca
• BioCryst Pharmaceuticals.Inc.
• CSL Limited
• Emergent Biosolutions
• GlaxoSmithKline
• Protein Sciences Corporation
• Sanofi Pasteur, Inc.
• Serum Institute Of India Pvt. Ltd.

For more information about this report visit http://www.researchandmarkets.com/research/cb3xsq/global_influenza

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Infectious Diseases Drugs, Vaccines